InfuSystem Holdings (INFU) Research & Development (2010 - 2026)
InfuSystem Holdings' (INFU) quarterly Research & Development came in at $3.1 million in Q1 2026, up 3.18% YoY from $3.0 million in Q1 2025, and up 26.64% on a QoQ basis from $2.4 million in Q4 2025.
InfuSystem Holdings (INFU) Research & Development (2010 - 2026) Analysis & Trends
InfuSystem Holdings (INFU) has 17 years of Research & Development data on file, last reported at $3.1 million in Q1 2026.
- Quarterly Research & Development rose 3.18% year-over-year to $3.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.6 million (down 3.1% YoY) and the FY2025 annual result came in at $10.5 million, down 7.29% from the prior year.
- Research & Development advanced to $3.1 million in Q1 2026, from $2.4 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $3.7 million in Q4 2023 to a low of $2.1 million in Q4 2024.
- A 5-year average of $2.9 million and a median of $3.0 million in 2023 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2022 — Research & Development jumped 39.69% — and 2024, when it sank 42.45%.
- Tracing INFU's Research & Development over 5 years: stood at $3.0 million in 2022, then rose by 25.45% to $3.7 million in 2023, then slumped by 42.45% to $2.1 million in 2024, then rose by 13.7% to $2.4 million in 2025, then gained by 26.64% to $3.1 million in 2026.
- The last three Research & Development figures came in at $3.1 million (Q1 2026), $2.4 million (Q4 2025), and $2.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.12 Bn | 193.52 Bn | 7.27 Bn | 892.00 Mn |
| 2 | Stryker | 128.79 Bn | 125.32 Bn | 4.50 Bn | 434.00 Mn |
| 3 | Medtronic | 119.30 Bn | 110.08 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 73.50 Bn | 72.96 Bn | 3.85 Bn | 554.00 Mn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.86 Bn | 1.35 Bn | 278.90 Mn |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn | 153.00 Mn |
| 7 | GE HealthCare Technologies | 34.05 Bn | 31.94 Bn | 2.18 Bn | 323.00 Mn |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn | -562.58 Mn |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | 28.60 Mn |
| 10 | InfuSystem Holdings | 245.67 Mn | 244.71 Mn | 21.41 Mn | 2.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.99 Mn |
| Mar 31, 2026 | 3.08 Mn |
| Dec 31, 2025 | 2.43 Mn |
| Sep 30, 2025 | 2.37 Mn |
| Jun 30, 2025 | 2.70 Mn |
| Mar 31, 2025 | 2.99 Mn |
| Dec 31, 2024 | 2.14 Mn |
| Sep 30, 2024 | 2.76 Mn |
| Jun 30, 2024 | 3.04 Mn |
| Mar 31, 2024 | 3.38 Mn |
| Dec 31, 2023 | 3.72 Mn |
| Sep 30, 2023 | 2.73 Mn |
| Jun 30, 2023 | 2.99 Mn |
| Mar 31, 2023 | 3.22 Mn |
| Dec 31, 2022 | 2.96 Mn |
| Sep 30, 2022 | 2.89 Mn |
| Jun 30, 2022 | 3.08 Mn |
| Mar 31, 2022 | 3.32 Mn |
| Dec 31, 2021 | 2.81 Mn |
| Sep 30, 2021 | 2.91 Mn |